Prospective Study of Alternating Chemoradiotherapy Consisting of Extended-Field Dynamic Conformational Radiotherapy and Systemic Chemotherapy Using 5-FU and Nedaplatin for Patients in High-Risk Group With Cervical Carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 1, 2009, Pages 251-258

  Kodaira, Takeshi ^a   Fuwa, Nobukazu ^a   Nakanishi, Toru ^a   Tachibana, Hiroyuki ^a   Nakamura, Tatsuya ^a   Tomita, Natsuo ^a   Nakahara, Rie ^a   Inokuchi, Haruo ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Alternating chemoradiotherapy; Cervical cancer; Conformational radiotherapy; Extended field; Nedaplatin

Indexed keywords

BLOOD VESSELS; CHEMOTHERAPY; DECISION MAKING; DISEASE CONTROL; IRRADIATION; MAGNETIC RESONANCE IMAGING; MULTIVARIANT ANALYSIS; POPULATION STATISTICS; RADIOTHERAPY; TOXICITY;

ALTERNATING CHEMORADIOTHERAPY; CERVICAL CANCER; CONFORMATIONAL RADIOTHERAPY; EXTENDED FIELD; NEDAPLATIN;

RISK MANAGEMENT;

FLUOROURACIL; NEDAPLATIN;

ADULT; AGED; ALTERNATING CHEMORADIOTHERAPY; ANEMIA; ARTICLE; BLADDER DISEASE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; DIARRHEA; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; FEVER; FOLLOW UP; GRANULOCYTOPENIA; HIGH RISK POPULATION; HUMAN; INFECTION; KIDNEY DYSFUNCTION; LEUKOPENIA; LIVER DYSFUNCTION; LYMPH NODE; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; NAUSEA AND VOMITING; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROPHYLAXIS; PROSPECTIVE STUDY; RECOMMENDED DRUG DOSE; RECTUM DISEASE; RISK ASSESSMENT; STOMATITIS; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TIME SERIES ANALYSIS; TUMOR VOLUME; UTERINE CERVIX CARCINOMA; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HUMANS; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; PROSPECTIVE STUDIES; RADIOTHERAPY, CONFORMAL; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 57649110845     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.03.049     Document Type: Article

References (30)

1. Green J.A., Kirwan J.M., Tierney J.F., et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systematic review and meta-analysis. Lancet 358 (2001) 781-786
2. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340 (1999) 1144-1153
3. Peters III W.A., Liu P.Y., Barrett II R.J., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18 (2000) 1606-1613
4. Morris M., Eifel P.J., Lu J., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340 (1999) 1137-1143
5. Eifel P.J., Winter K., Morris M., et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 22 (2004) 872-880
6. Rose P.G., Ali S., Watkins E., et al. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: A Gynecologic Oncology Group Study. J Clin Oncol 25 (2007) 2804-2810
7. Adachi S., Ogasawara T., Wakimoto E., et al. Phase I/II study of intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical carcinoma. Cancer 91 (2001) 74-79
8. Yoshinaga K., Niikura H., Ogawa Y., et al. Phase I trial of concurrent chemoradiation with weekly nedaplatin in patients with squamous cell carcinoma of the uterine cervix. Gynecol Oncol 104 (2007) 36-40
9. Fuwa N., Kodaira T., Kamata M., et al. Phase I study of combination chemotherapy with 5-fluorouracil (5-FU) and nedaplatin (NDP): Adverse effects and recommended dose of NDP administered after 5-FU. Am J Clin Oncol 25 (2002) 565-569
10. Fuwa N., Kano M., Toita T., et al. Alternating chemoradiotherapy for nasopharyngeal cancer using cisplatin and 5-fluorouracil: A preliminary report of phase II study. Radiother Oncol 61 (2001) 257-260
11. Kodaira T., Fuwa N., Kamata M., et al. Clinical assessment by MRI for patients with stage II cervical carcinoma treated by radiation alone in multicenter analysis: Are all patients with stage II disease suitable candidates for chemoradiotherapy?. Int J Radiat Oncol Biol Phys 52 (2002) 627-636
12. Kodaira T., Fuwa N., Toita T., et al. Comparison of prognostic value of MRI and FIGO stage among patients with cervical carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 56 (2003) 769-777
13. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
14. Kodaira T., Fuwa N., Kamata M., et al. Single-institute phase I/II trial of alternating chemoradiotherapy with 5-FU and nedaplatin for esophageal carcinoma. Anticancer Res 26 (2006) 471-478
15. Kodaira T., Fuwa N., Nakanishi T., et al. Long-term clinical outcomes of postoperative pelvic radiotherapy with or without prophylactic paraaortic irradiation for stage I-II cervical carcinoma with positive lymph nodes: Retrospective analysis of predictive variables regarding survival and failure patterns. Am J Clin Oncol 27 (2004) 140-148
16. Kaplan E., and Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc 53 (1958) 457-481
17. Mantle N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50 (1966) 163-170
18. Cox D. Regression models and life table. J R Stat Soc 34 (1972) 197-220
19. Whitney C.W., Sause W., Bundy B.N., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17 (1999) 1339-1348
20. Sasaoka M., Fuwa N., Asano A., et al. Patterns of failure in carcinoma of the uterine cervix treated with definitive radiotherapy alone. Am J Clin Oncol 24 (2001) 586-590
21. Kodaira T., Fuwa N., Nakanishi T., et al. Retrospective analysis of postoperative radiotherapy for node-negative cervical carcinoma with stage IB-IIB disease. Jpn J Clin Oncol 32 (2002) 255-261
22. Small Jr. W., Winter K., Levenback C., et al. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: Results of ARM 1 of RTOG 0116. Int J Radiat Oncol Biol Phys 68 (2007) 1081-1087
23. Varia M.A., Bundy B.N., Deppe G., et al. Cervical carcinoma metastatic to para-aortic nodes: Extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: A Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 42 (1998) 1015-1023
24. Grigsby P.W., Heydon K., Mutch D.G., et al. Long-term follow-up of RTOG 92-10: Cervical cancer with positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys 51 (2001) 982-987
25. Malfetano J.H., and Keys H. Aggressive multimodality treatment for cervical cancer with paraaortic lymph node metastases. Gynecol Oncol 42 (1991) 44-47
26. Podczaski E., Stryker J.A., Kaminski P., et al. Extended-field radiation therapy for carcinoma of the cervix. Cancer 66 (1990) 251-258
27. Kodaira T., Karasawa K., Shimizu T., et al. Clinical efficacy of applying four-field portals to paraaortic irradiation in the treatment of cervical carcinoma. Radiat Oncol Investig 7 (1999) 170-177
28. Thomas G.M. Concurrent chemotherapy and radiation for locally advanced cervical cancer: The new standard of care. Semin Radiat Oncol 10 (2000) 44-50
29. Sasaki Y., Amano T., Morita M., et al. Phase I study and pharmacological analysis of cis-diammine(glycolato)platinum (254-S; NSC 375101D) administered by 5-day continuous intravenous infusion. Cancer Res 51 (1991) 1472-1477
30. Fuwa N., Shikama N., Hayashi N., et al. Treatment results of alternating chemoradiotherapy for nasopharyngeal cancer using cisplatin and 5-fluorouracil-a phase II study. Oral Oncol 43 (2007) 948-955